Substandard and Falsified Medicines in Myanmar [PDF]
Background: substandard and falsified medicines (SFMs) are a threat to public health. The availability of SFMs in Myanmar was reported by the World Health Organization (WHO) in 1999, but there have been few systematic surveys on falsified medicines in ...
Naoko Yoshida +2 more
exaly +9 more sources
Falsified Medicines—Bridging the Gap between Business and Public Health [PDF]
The pharmaceutical industry is one of the most regulated industries in the world. While legislation is necessary to protect patients, too much legislation is said to hamper innovation and increase medicine prices.
Rasmus Borup
exaly +11 more sources
A Cross-Sectional Investigation for Verification of Globalization of Falsified Medicines in Cambodia, Indicated by Tablets of Sildenafil Citrate [PDF]
Medicine falsification is a global issue. Viagra, an erectile dysfunction therapeutic (EDT) medicine consisting primarily of sildenafil citrate, is the most commonly falsified medicine worldwide.
Naoko Yoshida +2 more
exaly +6 more sources
Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance [PDF]
The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and middle-income countries.
Elizabeth Pisani +5 more
doaj +4 more sources
Sounding out falsified medicines from genuine medicines using Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) [PDF]
The trade in falsified medicine has increased significantly and it is estimated that global falsified sales have reached $100 billion in 2020. The EU Falsified Medicines Directive states that falsified medicines do not only reach patients through illegal
Anas Alfarsi +9 more
doaj +4 more sources
Substandard and falsified medicines in Africa: healthcare systems challenges, supply chain issues, regulatory challenges and strategies to increase access to quality medicines [PDF]
Africa is a unique continent due to high disease burden for both communicable and non-communicable diseases, attracting large-scale distribution of medicines to tackle public health issues.
Billy Chabalenge +3 more
doaj +5 more sources
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance [PDF]
Approximately 10% of antimicrobials used by humans in low- and middle-income countries are estimated to be substandard or falsified. In addition to their negative impact on morbidity and mortality, they may also be important drivers of antimicrobial ...
Sean Cavany +9 more
doaj +4 more sources
The impact of global falsified medicines regulation on healthcare stakeholders in the legitimate pharmaceutical supply chain: a systematic review [PDF]
BackgroundFalsified medicines and their international regulation impacts all healthcare sectors and their actors. These regulations aim to strengthen and protect the global pharmaceutical supply chain against falsified medicines.
Bernard Naughton
exaly +4 more sources
Pharmacists' views on the impact of the Falsified Medicines Directive on community pharmacies: A cross-sectional survey [PDF]
Background: The Falsified Medicines Directive (FMD) was implemented to minimise the circulation of falsified medicines in the legal pharmaceutical supply chain.
Kevin D Murphy, Kieran Dalton
exaly +4 more sources
Current challenges in the detection and analysis of falsified medicines
Falsified medicines affect public health all around the globe. Complex distribution routes, illegal online webshops and reuse of packaging materials make them hard to detect. In order to tackle this problem, detection methods for the recognition of suspicious medicines and subsequent confirmation of falsification by analytical techniques is required ...
Bastiaan Venhuis +1 more
exaly +5 more sources

